Systemic cytokine profiles in biliary atresia

PLoS One. 2022 Apr 22;17(4):e0267363. doi: 10.1371/journal.pone.0267363. eCollection 2022.

Abstract

Background: Inflammation and immune dysregulation persuade biliary duct injury in biliary atresia (BA), a leading cause of pediatric liver transplantation given lack of specific biomarkers. We aimed to determine associations between systemic cytokine profiles and clinical parameters in BA patients and to identify potential BA biomarkers.

Methods: Systemic levels of 27 cytokines were measured in 82 BA patients and 25 healthy controls using a multiplex immunoassay. Relative mRNA expressions of candidate cytokines in 20 BA livers and 5 non-BA livers were assessed using quantitative real-time PCR.

Results: Higher levels of 17 cytokines including IL-1β, IL-6, IL-7, IL-8, IL-9, IL-2, IL-15, eotaxin, IP-10, MCP-1, MIP-1α, MIP-1β, G-CSF, IL-1ra, IL-4, IL-5, and IL-10 and lower levels of IFN-α and PDGF were significantly associated with BA. In BA patients, increased levels of IL-7, eotaxin, IP-10, and IL-13 were significantly associated with unfavorable outcomes including jaundice, fibrosis, and portal hypertension. Indeed, systemic levels of those cytokines were significantly correlated with clinical parameters indicating jaundice, fibrosis, and hepatic dysfunction in BA patients. Out of 27 cytokines, 4 (IL-8, IP-10, MCP-1, and PDGF) had potential as sensitive and specific biomarkers of BA. Of these, higher IL-8 levels were significantly associated with reduced survival of BA. In BA livers, relative mRNA expressions of IL-8, IP-10, and MCP-1 were significantly up-regulated.

Conclusions: Higher levels of several cytokines including inflammatory cytokines, immunomodulatory cytokines, chemokines, and anti-inflammatory cytokines and lower levels of growth factors would reflect inflammatory and immune responses related to BA development. Among 27 cytokines, plasma IL-8 might have great potential as a diagnostic and prognostic biomarker for BA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biliary Atresia*
  • Biomarkers
  • Chemokine CXCL10
  • Child
  • Cytokines / metabolism
  • Fibrosis
  • Humans
  • Interleukin-7
  • Interleukin-8
  • Jaundice*
  • RNA, Messenger

Substances

  • Biomarkers
  • Chemokine CXCL10
  • Cytokines
  • Interleukin-7
  • Interleukin-8
  • RNA, Messenger

Grants and funding

This research project is supported by Mahidol University (Basic Research Fund: fiscal year 2021) and Osteoarthritis and Musculoskeleton Research Unit, Faculty of Medicine, Ratchadapiseksompotch Fund, Chulalongkorn University (CUGR63953002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.